e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
219.76
-1.69 (-0.76%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,405,719
Open
222.04
Bid (Size)
219.75 (500)
Ask (Size)
220.00 (200)
Prev. Close
221.45
Today's Range
219.76 - 223.28
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.15%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
My Top 3 Dividend Kings to Buy for March 2026
↗
March 17, 2026
Only the best dividend stocks can achieve "king" status.
Via
The Motley Fool
My 5 Favorite Dividend Stocks to Buy Right Now
↗
March 15, 2026
There are lots of choices, but these are at the top of my list.
Via
The Motley Fool
Topics
Retirement
Performance
YTD
-4.2%
-4.2%
1 Month
-5.6%
-5.6%
3 Month
-1.7%
-1.7%
6 Month
+1.6%
+1.6%
1 Year
+2.5%
+2.5%
More News
Read More
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities
↗
March 13, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
ABBVIE INC (NYSE:ABBV) Shows Strong Technical Setup for Potential Breakout
↗
March 06, 2026
Via
Chartmill
The Best Dividend Stocks to Buy and Hold Forever
↗
March 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm
↗
March 11, 2026
Via
The Motley Fool
Topics
Intellectual Property
Quiet Outperformance From an Overlooked Dividend ETF
↗
March 09, 2026
Via
MarketBeat
1 Momentum Stock to Consider Right Now and 2 We Ignore
March 09, 2026
Via
StockStory
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
↗
March 06, 2026
Via
MarketBeat
AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?
March 05, 2026
Via
StockStory
Topics
Stocks
Supply Chain
AbbVie: The Only Big Pharma Stock I'd Consider a Buy‑and‑Never‑Sell
↗
March 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
March 03, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Retirement
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors
↗
March 02, 2026
Via
The Motley Fool
Topics
Economy
Where Will AbbVie Be in 5 Years?
↗
February 26, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises
↗
February 25, 2026
Via
Stocktwits
Topics
Intellectual Property
This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income
↗
February 24, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
Axsome Therapeutics (AXSM): A CNS Powerhouse at a Commercial Crossroad
February 23, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
1 Cash-Producing Stock to Target This Week and 2 We Ignore
February 22, 2026
Via
StockStory
3 Stocks to Buy and Hold for 2026 and Beyond
↗
February 19, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
2 Dividend Stocks to Hold for the Next 5 Years
↗
February 19, 2026
Via
The Motley Fool
Topics
Energy
Intellectual Property
What's going on in today's session: S&P500 movers
↗
February 18, 2026
Via
Chartmill
6 Forever Dividend Stocks
↗
February 18, 2026
Via
The Motley Fool
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
February 17, 2026
Via
StockStory
8 Cheap Stocks to Buy in 2026
↗
February 16, 2026
Via
The Motley Fool
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 219.76
When was AbbVie last traded?
The last trade of AbbVie was at 03/17/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.